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ABSTRACT
In order to clarify the airway physiology of NC mice,
the following experiments were carried out. To investi-
gate inherent airway reactivity, we compared tracheal
reactivity to various chemical mediators in NC,
BALB/c, C57BL/6 and A/J mice in vitro. NC mice
showed significantly greater reactivity to acetylcholine
than BALB/c and C57BL/6 mice and a reactivity com-
parable to that of A/J mice, which are known as high
responders. Then, airway reactivity to acetylcholine
was investigated in those strains in vivo. NC mice
again showed comparable airway reactivity to that
seen in A/J mice and a significantly greater reactivity
than that seen in BALB/c and C57BL/6 mice. To inves-
tigate the effects of airway inflammation on airway
reactivity to acetylcholine in vivo, NC and BALB/c mice
were sensitized to and challenged with antigen.
Sensitization to and challenge with antigen induced
accumulation of inflammatory cells, especially
eosinophils, in lung and increased airway reactivity in
NC and BALB/c mice. These results indicate that NC
mice exhibit inherent and antigen-induced airway
hyperreactivity. Therefore, NC mice are a suitable
strain to use in investigating the mechanisms underly-
ing airway hyperreactivity and such studies will provide
beneficial information for understanding the patho-
physiology of asthma.
Key words: airway hyperreactivity, asthma, genetic
regulation, inbred strains, inflammation, NC mice.
INTRODUCTION
NC mice have biologically characteristic features, such
as high susceptibility to X-irradiation, a high number of
mast cells in the subcutaneous tissue and high suscepti-
bility to anaphylactic shock from ovalbumin (OVA).1–2
Recently, it has been reported that NC mice sponta-
neously develop symptoms that are histologically and
clinically similar to human atopic dermatitis, with IgE pro-
duction and increasing numbers of granulated mast cells
in a conventional environment.3 However, little is known
about the airway reactivity of NC mice.
It is now well recognized that one of the characteristic
features of asthma is airway hyperreactivity to non-
specific stimuli.4 Airway reactivity is influenced by both
genetic and environmental factors. There are several
reports on genetic control of airway hyperreactivity in
animals5–8 and humans.9–11 Environmental factors, such
as antigen exposure12–14 or activation of mast cells by
anti-IgE15 cause airway inflammation and lead to airway
hyperreactivity in animal models.
In the present study, to clarify characteristics of airway
reactivity in NC mice, inherent airway reactivity in NC,
BALB/c, C57BL/6 and A/J mice was investigated in vitro
and in vivo. It had been reported previously that C57BL/6
mice are low responders and A/J mice are high respon-
ders to acetylcholine and serotonin (5-HT) in vivo.5 The
effects of airway inflammation, caused by sensitization to
and challenge with antigen, on airway reactivity to acetyl-
choline were also investigated in NC and BALB/c mice 
in vivo.
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MATERIALS AND METHODS
Animals
BALB/c, C57BL/6 and A/J mice were purchased from
Japan SLC Inc. (Hamamatsu, Japan). NC mice were pur-
chased from Clea Japan Inc. (Tokyo, Japan). Mice were
housed under specific pathogen-free (SPF) conditions
with free access to water and a standard laboratory diet.
Measurement of tracheal reactivity in vitro
Mice were killed and the trachea was carefully removed
from each animal and transferred to a Petri dish filled
with Tyrode solution (composition in mmol/L: NaCl
137.0, KCl 2.68, CaCl2 1.89, MgCl2 1.09, NaHCO3
11.9, NaH2PO4 0.42, glucose 5.6, pH 7.4). The trachea
was prepared free of excess tissue and cut into zig-zag
strips according to the method of Akeasu.16 The tracheal
segment preparations were mounted in an organ bath
filled with 10 mL Tyrode solution and connected to 
a force-displacement transducer (AP-621G; Nihon
Kohden Co., Tokyo, Japan) for registration of the isomet-
ric tension on a two-channel recorder (FBR-252A; TOA
Electronics Ltd, Tokyo, Japan). The Tyrode solution was
aerated with a mixture of oxygen (95%) and carbon
dioxide (5%). Temperature was maintained at 37°C with a
constant temperature circulating unit. The resting tension
of the preparations was set at 0.5 g and preparations
were allowed to equilibrate for 1 h. During the equilibra-
tion, the bath fluid was exchanged every 15 min. Test
compounds were added in the tonic phase of the con-
traction. Results are presented as the percentage of the
maximal contraction obtained in response to 50 mmol/L
KCl.
Measurement of airway reactivity in vivo
In order to measure airway reactivity to acetylcholine,
mice were anesthetized with sodium pentobarbitone 
(100 mg/kg; Dainabot Co., Osaka, Japan) by i.p. injec-
tion and the tracheas were surgically exposed and
cannulated. The tracheal cannula was then connected to
a rodent ventilator (Model 683; Harvard Apparatus,
South Natick, MA, USA) and a bronchospasm transducer
(Model 7020; Ugo Basile, Comerio-Varese, Italy). Mice
were mechanically ventilated with air supplemented at
60 strokes/min, with a stroke volume of 0.6 mL.
Bronchoconstriction was measured according to the
overflow method described by Konzett and Rössler.17
After administration of a paralytic agent (pancuronium
bromide, 0.1 mg/kg; Sigma Chemical Co., St Louis,
MO, USA), airway constriction was measured by deter-
mining changes in respiratory overflow volume during
cumulative i.v. injection of acetylcholine. The increase in
respiratory overflow volume provoked by acetylcholine
was represented as a percentage of the maximal overflow
(100%) obtained by clamping the trachea cannula. Area
under the curve (AUC) was calculated from the results of
the dose–response curve for acetylcholine.
Protocol of sensitization and inhalation 
challenge
The sensitization protocol conformed to the method
described by Kung et al.18 with slight modifications.
Briefly, mice were actively sensitized by i.p. injection of
10 m g OVA with 1 mg alum on days 0 and 5. Then,
mice were exposed to OVA (5 mg/mL in 0.9% NaCl
solution) for 10 min on days 12, 16 and 20, by an ultra-
sonic nebulizer (NE-U12; Omron, Tokyo, Japan).
Twenty-four hours after the last antigen exposure, 
measurement of airway reactivity and collection of
bronchoalveolar lavage fluid (BALF) were performed.
Collection of lung cells
Bronchoalveolar lavage fluid was collected by lavaging
the whole lung via the tracheal cannula with 4 · 0.7 mL
saline containing 0.1% bovine serum albumin (BSA) at
room temperature. The BALF obtained from one animal
was pooled, centrifuged and resuspended in 100 m L
saline containing 0.1% BSA. Then, cell numbers were
determined using a standard hemocytometer and
5 · 104 cells were spun onto glass slides and differen-
tially stained by Diff-Quik (International Reagent Co.,
Kobe, Japan). Cell types were identified by morphologi-
cal criteria. Two hundred cells were counted on each
slide.
Measurement of serum IgE
Ovalbumin-specific IgE in sera was measured according
to the enzyme-linked immunosorbent assay (ELISA)
method described by Tomura et al.19 with slight modifi-
cations. Briefly, 96-well microtiter plates (Nunc,
Roskilde, Denmark) were coated with 3 m g/mL rat anti-
mouse IgE monoclonal antibody R35-72 (Pharmingen,
San Diego, CA, USA). After blocking with SuperBlock
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(Pierce, Rockford, IL, USA) and washing with Tris-
buffered saline containing 0.05% Tween 20 (TBST),
appropriate dilution of samples in TBST containing 1%
BSA were added to the plate. After overnight incubation
at 4°C, plates were washed and 1.4 m g/mL biotinylated
OVA was added to each well. Biotinylation of OVA was
performed using a biotinylation kit (Amersham Co.,
Arlington Heights, IL, USA). The plates were incubated
for 1 h at room temperature and washed. Then, the
binding of the antibody was measured using alkaline
phosphatase-streptavidin conjugate (Zymed, San
Francisco, CA, USA) and an alkaline phosphatase 
colormerizing kit (AMPAK; DAKO Japan Co., Kyoto,
Japan) for amplification of the colorimetric signal. A
serum pool from OVA-sensitized mice was used as an
internal laboratory standard.
Statistics
Homogeneity of variance was tested by the F-test. The
Student’s t-test was applied in cases where the variance
was homogeneous, and Aspin-Welch’s test was per-
formed when the variance was heterogeneous. A P value
of less than 0.05 was considered significant. Values for
all measurements are expressed as mean ± SEM.
RESULTS
Tracheal reactivity to acetylcholine, 5-HT and
histamine in A/J, NC, BALB/c and C57BL/6
mice in vitro
Reactivity of the tracheal segment removed from each
mouse to increasing doses of acetylcholine, 5-HT and
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Fig. 1 Tracheal reactivity to acetylcholine (ACh) in various
murine strains in vitro. Dose–response curves to ACh were
measured in A/J (s, n = 4), NC (d, n = 5), BALB/c (n,
n = 4) and C57BL/6 (m, n = 4) mice. Results are expressed as
the mean ± SEM. 
Table 1 Comparison of tracheal reactivity to various chemical mediators between A/J, NC, BALB/c and C57BL/6 mice
Results are presented as the percentage of maximal contraction obtained in response to 50 mmol/L KCl and are expressed as the mean ± SEM
of four to five mice. ND, not detected.*P < 0.001 compared with C57BL/6 mice; †P < 0.001, ‡P < 0.05 compared with BALB/c mice. ACh, acetyl-
choline; 5-HT, serotonin.
Fig. 2 Bronchial reactivity to acetylcholine (ACh) in various
murine strains in vivo. Dose–response curves to intravenous
injection of ACh were measured in A/J (s), NC (d), BALB/c
(n) and C57BL/6 (m) mice. Results are expressed as the
mean ± SEM. For each group, n = 6 mice.
ACh (10–4 mol/L) 5-HT (10–4 mol/L) Histamine (10–4 mol/L)
A/J 79.53 ± 1.38*† 13.85 ± 2.30 ND
NC 85.76 ± 2.55*† 18.48 ± 2.82‡ ND
BALB/c 38.78 ± 5.27 9.38 ± 1.05 ND
C57BL/6 32.60 ± 1.94 9.50 ± 2.10 ND
histamine was measured. Dose–response curves for
acetylcholine are shown in Fig. 1. NC mice showed
greater reactivity to acetylcholine than BALB/c and
C57BL/6 mice and reactivity comparable to that in 
A/J mice, which are known as high responders.
Comparisons of tracheal reactivity to acetylcholine, 5-HT
and histamine at a dose of 10–4 mol/L are summarized in
Table 1. NC mice showed significantly greater reactivity
to 5-HT than BALB/c mice. NC mice showed a greater
tendency to respond to 5-HT than did C57BL/6 and A/J
mice but the difference was not significant. In each strain,
5-HT produced less reactivity than acetylcholine. BALB/c
and C57BL/6 mice showed comparable airway reactivity
to acetylcholine and to 5-HT (Fig. 1; Table 1). None of
the strains responded to histamine up to 3 · 10–4 mol/L.
Leukotriene C4 and platelet-activating factor did not
provoke tracheal contraction up to 10–9 mol/L and
3 · 10–6 mol/L, respectively.
Airway reactivity to acetylcholine in A/J, NC,
BALB/c and C57BL/6 mice in vivo
Bronchoconstriction provoked by intravenous injection of
increasing doses of acetylcholine was measured.
Dose–response curves are shown in Fig. 2. At a dose of
4000 m g/kg, NC, A/J, BALB/c and C57BL/6 mice
showed 60.72%, 49.86%, 24.72% and 9.36% of
maximal constriction, respectively. Values of AUC
obtained from dose–response curves are summarized in
Table 2. Values of AUC revealed that NC mice showed
greater reactivity than BALB/c and C57BL/6 mice and
reactivity comparable to that of A/J mice. BALB/c mice
showed greater reactivity than C57BL/6 mice.
Antibody responses to OVA sensitization and
cellular composition of BALF in BALB/c and
NC mice
BALB/c and NC mice were actively sensitized to and
challenged with OVA. Peripheral blood samples were
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Table 2 Comparison of area under the curve values
between A/J, NC, BALB/c and C57BL/6 mice
Values of the area under the curve (AUC) were obtained from the
dose–response curves shown in Fig. 2. Values are expressed as the
mean ± SEM of six mice. *P < 0.01 compared with BALB/c mice; 
† P < 0.01 compared with C57BL/6 mice.
Fig. 3 (a) Serum levels of ovalbumin (OVA)-specific IgE antibodies and (b) cellular composition of bronchoalveolar lavage fluid
(BALF) in BALB/c and NC mice ( , macrophages; n, lymphocytes; , eosinophils; , neutrophils). Ovalbumin-specific IgE anti-
bodies and cellular composition of BALF were determined in mice after sensitization and challenge (n = 7), mice receiving
challenge alone (n = 6) and intact mice (n = 6). Results are expressed as the mean ± SEM for each group. Saline-OVA, challenge
alone; OVA-OVA, sensitized and challenged.
Strain AUC
A/J 46.17 ± 4.78*†
NC 40.29 ± 2.99*†
BALB/c 17.59 ± 1.74†
C57BL/6 10.52 ± 0.51
collected from the retro-orbital sinus at day 20. Active
sensitization to and challenge with OVA caused elevation
of serum levels of OVA-specific IgE in both strains. The
increasing levels were comparable in BALB/c and NC
mice (Fig. 3a). For both strains, neither intact mice, which
did not receive either sensitization or challenge, nor mice
receiving challenge alone showed an IgE response.
Leukocyte accumulation in BALF is shown in Fig. 3(b).
In intact mice and mice receiving challenge alone,
macrophages were the predominant cell type accumu-
lated in BALF. In contrast, sensitization and challenge
caused accumulation predominantly of eosinophils, 
with a relatively low accumulation of lymphocytes and 
neutrophils in both strains. The number of lymphocytes,
eosinophils and neutrophils in sensitized and challenged
groups were comparable for both strains.
Antigen-induced airway hyperreactivity to
acetylcholine in BALB/c and NC mice
Changes in airway reactivity to acetylcholine by sensitiza-
tion to and challenge with antigen in BALB/c and NC mice
were investigated. Dose–response curves for acetylcholine
are shown in Fig. 4. In this experiment, again, intact NC
mice showed inherent airway hyperreactivity (Fig. 4b)
when compared with intact BALB/c mice (Fig. 4a).
Accumulation of inflammatory cells in the peribronchial
tissue and histological lesion was not observed in intact
NC mice (data not shown). The AUC values obtained
from dose–response curves are summarized in Table 3. In
BALB/c mice, the intact group and mice receiving chal-
lenge alone showed comparable airway reactivity. Airway
hyperreactivity was observed in mice receiving both sensi-
tization and challenge. In NC mice, mice receiving
sensitization and challenge had increased airway reactiv-
ity compared with the intact group (P < 0.01). Mice
receiving challenge alone showed a tendency toward
increased airway reactivity compared with the intact
group, but the difference was not significant.
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Fig. 4 Bronchial reactivity to acetylcholine (ACh) in (a) BALB/c and (b) NC mice in vivo. Dose–response curves to intravenous
injection of ACh were measured in mice after sensitization and challenge (n; n = 7), mice receiving challenge alone (d; n = 6) and
intact mice (s; n= 6). Results are expressed as the mean ± SEM for each group.
Table 3 Comparison of area under the curve values in
BALB/c and NC mice
Values of the area under the curve (AUC) were obtained from the
dose–response curves shown in Fig. 4. Values are expressed as the
mean ± SEM of six to seven mice. Statistical analysis was performed
separately for each strain, between groups. * P < 0.01 compared with
the intact group; † P < 0.01 compared with the saline-ovalbumin
(OVA) group.
Strain Group AUC
BALB/c Intact 15.97 ± 1.18
BALB/c Saline-OVA 12.63 ± 1.12
BALB/c OVA-OVA 48.7 ± 7.84*†
NC Intact 26.66 ± 2.29
NC Saline-OVA 31.53 ± 4.50
NC OVA-OVA 40.98 ± 3.37*
DISCUSSION
Airway hyperreactivity is one of the characteristic features
of asthma.4 Airway reactivity is influenced by genetic
factors. In inbred strains of mice, there is a wide variabil-
ity in inherent airway reactivity between strains.5–7,20
Pauwels et al. showed similar variability of inherent
airway reactivity among inbred strains of rats.21 In the
present study, we demonstrated that NC mice, in the
absence of inflammation, showed high airway reactivity
to acetylcholine and 5-HT in vitro (Fig. 1; Table 1). In vivo
experiments revealed that NC mice also showed high
airway reactivity to acetylcholine comparable to that in
A/J mice, which are known as high responders (Fig. 2;
Table 2). In contrast, C57BL/6 and BALB/c mice showed
low airway reactivity to acetylcholine in vitro and in vivo.
Levitt and Mitzner reported that A/J mice showed high
reactivity to acetylcholine, while BALB/c and C57BL/6
showed low reactivity to acetylcholine in vivo.5 Our data
support those in vivo findings. Furthermore, we showed
that those in vivo findings were consistent with our results
in vitro. We also demonstrated that none of the strains
responded to histamine, while acetylcholine and 5-HT
were reactive in vitro. These results were consistent with
the previous in vivo findings that histamine does not
cause bronchoconstriction while acetylcholine and 5-HT
provoke bronchoconstriction in C57BL/6 mice.22
De Sanctis et al. demonstrated that airway reactivity is
a heritable trait, which is inherited as a dominant trait and
influenced by at least three loci that map to chromo-
somes 2, 15 and 17 in mice.6 These loci include several
candidate genes that may control airway reactivity. They
also demonstrated that T lymphoctyes were involved in
the regulation of inherent airway hyperreactivity.23
Nicolaides et al. reported that the interleukin (IL)-9 gene
is a candidate gene for regulating inherent airway reac-
tivity.24 Further experiments are required to determine the
cell(s) and/or gene(s) responsible for the regulation of
inherent airway hyperreactivity in NC mice. Analysis of
differences in sequences and expression patterns of can-
didate genes and differences in the function of T
lymphocytes between hyperreactive and hyporeactive
strains will provide beneficial information for understand-
ing the mechanisms underlying the pathophysiology of
asthma. As a hyperreactive strain, the NC murine strain,
together with the A/J strain, is suitable for use in such
experiments.
Airway reactivity is also considered to be influenced 
by environmental factors. It has been reported that
airway inflammation caused by antigen exposure12–14 or
activation of mast cells by anti-IgE15 leads to airway
hyperreactivity in animal models. We therefore investi-
gated the effects of sensitization and challenge with
antigen on airway reactivity to acetylcholine in NC and
BALB/c mice in vivo. Under SPF conditions, we could not
detect any IgE in intact NC mice (data not shown), which
coincided with a previous finding.3 Active sensitization by
OVA via the peritoneal cavity resulted in production of
IgE in both strains under SPF conditions. The levels of IgE
production were comparable in NC and BALB/c mice
(Fig. 3a). Matsuda et al. reported that in NC mice the
levels of total IgE spontaneously increased under conven-
tional conditions, but did not increase in BALB/c mice
under the same conditions.3 These differences may reflect
the high penetration of antigen via the skin in NC mice.
Sensitization and challenge with OVA induced dominant
accumulation of eosinophils with a small number of lym-
phocytes and neutrophils in BALF, but such induction was
not shown in mice receiving challenge alone (Fig. 3b). The
numbers of those inflammatory cells in BALF were compa-
rable in NC and BALB/c mice. The number of eosinophils
observed in BALF was relatively high in comparison with
previous reports.12,14,18 In our protocol of sensitization and
challenge, dominant accumulation of eosinophils is
observed reproducibly. Dose of antigen, timing of sec-
ondary sensitization and condition of challenge may
influence the number of eosinophils accumulated in lung.
Airway reactivity of NC mice was increased in the sensitized
and challenged group (compare the OVA-OVA group with
the intact group in Table 3), but the increase was relatively
small when compared with BALB/c mice. In the sensitized
and challenged group, NC and BALB/c mice exhibited 
comparable bronchoconstriction to acetylcholine at a dose
of 2000 m g/kg (63.86 ± 4.33% and 66.87 ± 7.19%,
respectively). NC mice showed greater airway reactivity
than BALB/c mice in the intact group, which may be one
of the reasons that NC mice in the sensitized group
exhibited a relatively small increase in airway reactivity
following antigen challenge. The role of eosinophils in
the development of airway hyperreactivity is contro-
versial in murine models of antigen-induced airway
hyperreactivity.13,25,26 Although a high number of
eosinophils was observed in our model, the role of
eosinophils is still unclear. Further experiments are
required to determine the role of inflammatory cells,
such as eosinophils, mast cells and T lymphocytes, and
possible molecule(s) in our model of antigen-induced
airway hyperreactivity.
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In conclusion, we have demonstrated that NC mice
show inherent airway hyperreactivity in vitro and in vivo.
Active sensitization to and challenge with antigen
increased airway reactivity to acetylcholine when com-
pared with an intact group of NC mice. These results
suggest that NC mice are a suitable strain for investiga-
tion of the mechanisms of airway hyperreactivity.
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